Epithelial Ovarian Cancer—Varied Treatment Results

Epithelial Ovarian Cancer—Varied Treatment Results

Ovarian cancer (OC) is the eighth most common cancer worldwide and is usually diagnosed in advanced stages. Despite many available data, no treatment results have been reviewed in Poland. This study enrolled 289 first-time patients treated between 2018 and 2021 by the Department of Oncology of the P...

Full description

Bibliographic Details
Main Authors:	Sonja Millert-Kalińska, Marcin Przybylski, Dominik Pruski, Małgorzata Stawicka-Niełacna, Radosław Mądry
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Healthcare
Subjects:	epithelial ovarian cancer EOC disparities in treatment laparoscopy in oncology cytoreduction
Online Access:	https://www.mdpi.com/2227-9032/11/14/2043

Similar Items

High-Volume Hospitals’ Ovarian Cancer Care—Less Individual Approach or Better Treatment Results?
by: Sonja Millert-Kalińska, et al.
Published: (2022-07-01)

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
by: Kyung Jin Eoh, et al.
Published: (2017-07-01)

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
by: Sipei Nie, et al.
Published: (2021-09-01)

High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer
by: Liwei Zhang, et al.
Published: (2022-02-01)

3D laparoscopy as a tertiary cytoreductive (TCR) surgery in infiltrating ureter recurrent epithelial ovarian cancer – case report and a mini-review of the literature
by: Tomasz Szopiński, et al.
Published: (2018-12-01)

RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer
by: Xuedong Wang, et al.
Published: (2023-11-01)

FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway
by: Minle Li, et al.
Published: (2021-12-01)

The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
by: Chao-Lien Liu, et al.
Published: (2021-07-01)

The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer
by: Mark W. Nachtigal, et al.
Published: (2022-07-01)

Epithelial ovarian cancer: Review article
by: Suchetha Sambasivan
Published: (2022-01-01)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
by: Emre Günakan, et al.
Published: (2020-01-01)

Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer
by: Henri Azaïs, et al.
Published: (2020-12-01)

Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma
by: Wei Lin, et al.
Published: (2022-07-01)

GPR12 Inhibits Apoptosis in Epithelial Ovarian Cancer via the Activation of ERK1/2 Signaling
by: Lu Wang, et al.
Published: (2022-07-01)

Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis
by: Anil Erturk, et al.
Published: (2020-11-01)

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
by: Valentina Tuninetti, et al.
Published: (2020-08-01)

Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria
by: Kehinde Sharafadeen Okunade, et al.
Published: (2020-08-01)

Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer
by: Anna Rebeka Kovács, et al.
Published: (2023-07-01)

Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer
by: Alexandros Laios, et al.
Published: (2022-04-01)

Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
by: Martín Salamini-Montemurri, et al.
Published: (2023-06-01)

Laparoscopy and computed tomography imaging in advanced ovarian tumors: A roadmap for prediction of optimal cytoreductive surgery
by: Ahmed Samy El-Agwany
Published: (2018-01-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
by: Ami Patel, et al.
Published: (2021-02-01)

A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression
by: Yue Teng, et al.
Published: (2016-11-01)

MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4
by: Deying Wang, et al.
Published: (2020-09-01)

Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
by: Jing He, et al.
Published: (2019-11-01)

Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
by: Yan Xu
Published: (2018-07-01)

Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion via the Wnt Pathway
by: Chang Xiong, et al.
Published: (2021-12-01)

Robotic resection of isolated ovarian cancer recurrence in the lesser sac
by: Jessica D. St. Laurent, et al.
Published: (2022-06-01)

Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer
by: Kehinde S Okunade, et al.
Published: (2023-12-01)

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients
by: Po-Chao Hsu, et al.
Published: (2021-09-01)

Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?
by: Stanislas Quesada, et al.
Published: (2023-07-01)

Unexpected epithelial ovarian cancers arising from presumed endometrioma: A 10-year retrospective analysis
by: Hsin-Hong Kuo, et al.
Published: (2017-02-01)

NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer
by: Elroy Saldanha, et al.
Published: (2023-01-01)

Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer
by: FLAVIO HENRIQUE FARIA, et al.
Published: (2022-11-01)

Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study
by: Caixia Jiang, et al.
Published: (2022-11-01)

A Cohort Study to Decode the Application of Peritoneal Carcinomatosis Index in Predicting the Prognosis of Advanced Ovarian Malignancies
by: Athul Damodaran, et al.
Published: (2022-04-01)

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints
by: Delphine Hudry, et al.
Published: (2022-10-01)

Residual Microscopic Peritoneal Metastases after Macroscopic Complete Cytoreductive Surgery for Advanced High-Grade Serous Ovarian Carcinoma: A Target for Folate Receptor Targeted Photodynamic Therapy?
by: Morgane Moinard, et al.
Published: (2022-08-01)

“Things Have Changed”—Laparoscopic Cytoreduction for Advanced and Recurrent Ovarian Cancer: The Experience of a Referral Center on 108 Patients
by: Marcello Ceccaroni, et al.
Published: (2023-12-01)